Traditional Medicine for the Treatment of Pulmonary Hypertension (PH): Is the Answer in the Nature?
A special issue of Medicina (ISSN 1648-9144).
Deadline for manuscript submissions: closed (1 August 2020) | Viewed by 5609
Special Issue Editors
Interests: pulmonary hypertension; high-altitude medicine; lung fibrosis
Interests: pulmonary hypertension; idiopathic pulmonary fibrosis; COPD; chronic lung diseases; therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the last two decades, a tremendous amount of scientific work has been done with a focus on the pathology/pathophysiology, underlying molecular mechanisms, and signalling pathways, in the field of pulmonary hypertension. Similarly, valuable clinical efforts were achieved, resulting in the discovery of several therapeutic options and strategies for the treatment of this disease. However, despite all the above-mentioned scientific and clinical efforts in the past, this severe and progressive pulmonary vascular disease is still enigmatic and incurable.
Accordingly, we have recently summarized the knowledge provided from outside of Western civilization and identified a plethora of different and potentially effective therapeutic options derived from natural plant products, including alkaloids, flavonoids, glycosides, diterpenoids, pyranocoumarins, and stilbenes (Kosanovic et al, Pulm Circ 2013; Xiang et al, Pulm Circ 2018). In particular, the “Materia Medica” of Ancient China could be a very useful and interesting starting point.
Therefore, the general topic of this Special Issue of the Medicina is about the potential future application of traditional medicine for the treatment of pulmonary hypertension. Both original studies and review papers are welcome. With regard to the original articles, the studies covering the systematic in vivo research using relevant animal models of pulmonary hypertension or profound in vitro work related to underlying molecular mechanisms and signalling pathways are both welcome. Finally, studies dealing with the investigation of the therapeutic potency of traditional medicine and natural products in humans are strongly desirable.
Dr. Djuro Kosanovic
Prof. Dr. Sergey Avdeev
Prof. Dr. Ghazwan Butrous
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Pulmonary hypertension: pathology
- Pulmonary hypertension: therapy
- Traditional medicine
- Traditional Chinese medicine
- Natural (plant) products
- Animal models and in vivo research
- Signalling pathways and molecular mechanisms.
